Investigating Novel Plasma-Based P-Tau Biomarkers

Investigating novel plasma-based P-tau biomarkers

Beyond Aβ and p-Tau: novel biomarkers under investigation for Alzheimer’s disease

Plasma p-tau as a biomarker for cerebral amyloid angiopathy diagnosis

Examining plasma vs. CSF p-tau217 in preclinical and prodromal Alzheimer’s disease

Latest knowledge on plasma p-tau in Alzheimer’s disease

Tau fragments as novel disease biomarkers: a pilot study for a plasma protein signature for AD

Predicting amyloid PET and tau PET stages with plasma biomarkers

Blood-based biomarkers for treatment monitoring in Alzheimer’s disease

The ability of plasma P-tau231 to detect preclinical Alzheimer’s disease

The potential of plasma biomarkers in dementia

Plasma biomarkers for population-based Alzheimer’s disease screening

Decoding #Alzheimer's Disease : The Truth Behind Blood #Biomarkers

Being Patient Alzheimer's

The use of Alzheimer’s disease plasma biomarkers in the clinic: further research needed

Comparing the performance of novel biomarkers across the spectrum of Alzheimer’s disease

Novel Imaging Biomarkers for Dementia Therapeutics

Yale Radiology and Biomedical Imaging

Using plasma biomarkers in the diagnosis of Alzheimer’s disease

Plasma biomarkers for Alzheimer's disease as pre-screening tools

Comparing plasma ptau217 with CSF biomarkers for predicting tau PET status

Upcoming plasma biomarkers for Alzheimer’s disease: Aβ, p-tau and GFAP